StockMarketWire.com - Verona Pharma has announced that the Board has, on 9 February 2016, granted options over 14,900,000 ordinary shares in the Company to one of its Directors and certain employees in accordance with the terms of the Companys share option plans.

Half of the Options will vest on 9 February 2018 and the other half on 9 February 2019. The Options have a ten-year exercise window from the date of grant.

Of the Options granted, 10,000,000 have been granted to Dr. Jan-Anders Karlsson, half of which have an exercise price of 4 pence per option and the other half have an exercise price of 6.6 pence per option.



At 2:54pm: [LON:VRP] Verona Pharma PLC share price was +0.05p at 3.3p



Story provided by StockMarketWire.com